Evidence map›Paper›PMID 32351672›Full record

ArticleOxidative medicine and cellular longevity2020

Picroside II Improves Severe Acute Pancreatitis-Induced Intestinal Barrier Injury by Inactivating Oxidative and Inflammatory TLR4-Dependent PI3K/AKT/NF-

Xuehua Piao, Baohai Liu, Xiaodan Sui, Shuangdi Li, Wei Niu, Qingyu Zhang, Xuan Shi, Shusheng Cai, Ying Fan

Open access · hybridAbstract read
In one paragraph

Article in Oxidative medicine and cellular longevity, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
9.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 60 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Xuehua PiaoDepartment of Traditional Chinese Medicine, The First affiliated Hospital, Jinzhou Medical University, Jinzhou 121001, China.ORCID https://orcid.org/0000-0003-3310-4183
Baohai LiuDepartment of Gastroenterology, The First affiliated Hospital, Jinzhou Medical University, Jinzhou 121001, China.ORCID https://orcid.org/0000-0003-0906-0379
Xiaodan SuiDepartment of Hepatology, The Affiliated Hospital of Changchun University of Traditional Chinese Medicine, 130021, China.
Shuangdi LiHeart Disease Center, The Affiliated Hospital of Changchun University of Traditional Chinese Medicine, Changchun 130021, China.
Wei NiuDepartment of Gastroenterology, The First affiliated Hospital, Jinzhou Medical University, Jinzhou 121001, China.
Qingyu ZhangDepartment of Gastroenterology, The First affiliated Hospital, Jinzhou Medical University, Jinzhou 121001, China.
Xuan ShiDepartment of Gastroenterology, The First affiliated Hospital, Jinzhou Medical University, Jinzhou 121001, China.
Shusheng CaiDepartment of Gastroenterology, The First affiliated Hospital, Jinzhou Medical University, Jinzhou 121001, China.
Ying FanDepartment of Gastroenterology, The First affiliated Hospital, Jinzhou Medical University, Jinzhou 121001, China.
Jinzhou Medical University · CNChangchun University · CNChangchun University of Chinese Medicine · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPicroside II exerts anti-inflammatory and antidiarrheal effects for treating the diseases associated with oxidative injury. However, its function on pancreatitis-induced intestinal barrier injury remains unclear.

resultsSEM showed that intestinal barrier injury was caused with the loss of intestinal villi and mitochondria destruction, and pathological scores were increased in the MG group. The levels of amylase, lipase, malondialdehyde, TNF

conclusionsPicroside II improved the SAP-induced intestinal barrier injury in the rat model by inactivating oxidant and inflammatory signaling and improving gut microbiota.

Indexed as

AnimalsCinnamatesFemaleGastrointestinal MicrobiomeHumansIridoid GlucosidesMalePancreatitisPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktRatsRats, Sprague-DawleySignal TransductionToll-Like Receptor 4CinnamatesIridoid GlucosidesPhosphatidylinositol 3-Kinasespicroside IIProto-Oncogene Proteins c-aktTLR4 protein, humanToll-Like Receptor 4

Identifiers

PMID32351672
PMCPMC7174951
OpenAlexW3015335608

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.